Maclan Pharmaceuticals Private Limited
About Maclan Pharmaceuticals Private Limited
Data last updated:
Maclan Pharmaceuticals Private Limited is a private limited company based in Jaipur, Rajasthan, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 September 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ2010PTC032899. Its GSTIN is 08AAGCM7807G1ZB (Rajasthan).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Anshul Chaturvedi and Pratibha Ojha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 70 Shalimar Bagh Ajmer Road, Jaipur, Rajasthan, India – 302021.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.34 Cr, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹4.97 Lakh (net margin 1.5%) and EBITDA of ₹9.57 Lakh (EBITDA margin 2.9%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 8% over five years.
The company is associated with 1 brand: Maclan Pharma. As per MCA filings, the company has open charges of ₹28 Lakh on record. Court records list 2 cases involving the company, including 2 filed against it; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address70 Shalimar Bagh Ajmer Road, Jaipur, Rajasthan, India – 302021
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Maclan Pharmaceuticals Private Limited
The main business activity of Maclan Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Maclan Pharmaceuticals Private Limited FY 2025 filings available
Maclan Pharmaceuticals Private Limited reported revenue of ₹3.34 Cr (up 9% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Maclan Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 9% growth in the latest year. EBITDA rose 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Maclan Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹9.57 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹4.97 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Maclan Pharmaceuticals Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Maclan Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Maclan Pharmaceuticals Private Limited
Maclan Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Can Pharmaceuticals Private Limited | ₹3.34 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Jaipur, Rajasthan, India |
| Ghrelin Pharmaceuticals Private Limited | ₹3.34 Cr (FY 2025) | •••• | •••• | 74.0% | •••• | Mumbai, Maharashtra, India |
| Bionics Remedies (Gujarat) Limited | ₹3.34 Cr (FY 2024) | •••• | •••• | 30.0% | •••• | Ahmedabad, Gujarat, India |
| Sai - Tech Pharmaceuticals Private Limited | ₹3.34 Cr (FY 2024) | •••• | •••• | -25.0% | •••• | Navi Mumbai, Maharashtra, India |
| Lipur Pharmaceuticals Private Limited | ₹3.34 Cr (FY 2024) | •••• | •••• | 33.0% | •••• | Patna, Bihar, India |
| Maclan Pharmaceuticals Private Limited this company | ₹3.34 Cr (FY 2025) | •••• | •••• | 9.0% | •••• | Jaipur, Rajasthan, India |
| Torin Pharmaceuticals Private Limited | ₹3.34 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Mumbai, Maharashtra, India |
| Phria Pharmaotech Private Limited | ₹3.34 Cr (FY 2024) | •••• | •••• | 33.0% | •••• | Navi Mumbai, Maharashtra, India |
| Prometheus Healthcare Private Limited | ₹3.34 Cr (FY 2024) | •••• | •••• | 65.0% | •••• | Thane, Maharashtra, India |
| Accosts Remedies Private Limited | ₹3.34 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Uttar Pradesh, India |
| Razenta Pharmaceuticals Private Limited | ₹3.34 Cr (FY 2025) | •••• | •••• | 70.0% | •••• | Indore, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Maclan Pharmaceuticals by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Maclan Pharmaceuticals Private Limited
Maclan Pharmaceuticals Private Limited is audited by R A KHANDELWAL & CO for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R A KHANDELWAL & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Maclan Pharmaceuticals Private Limited
Maclan Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anshul Chaturvedi | Director | 20 Sep 2010 | 16 Years 0 Months | Current |
| Pratibha Ojha | Director | 24 Apr 2012 | 14 Years 5 Months | Current |
Ownership and Shareholding of Maclan Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Maclan Pharmaceuticals Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jan 2025 | Others | ₹15 Lakh | Open |
| 05 Oct 2016 | Others | ₹13 Lakh | Open |
Total charge records: 2 View all charges
Legal Cases of Maclan Pharmaceuticals Private Limited
Maclan Pharmaceuticals Private Limited has 2 court cases on record: 2 filed against it. 1 case is pending and 1 is disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 1 |
Cases on record (2 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Jodhpur Metro, Rajasthan | Criminal case | Filed against the company by State of Rajasthan | Pending |
| District court, Alwar, Rajasthan | Criminal case | Filed against the company by State | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Associated Brands with Maclan Pharmaceuticals Private Limited
Maclan Pharmaceuticals operates one associated brand: Maclan Pharma. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Produces high-quality pharmaceutical products for various therapeutic areas. | maclanpharma.com |
Employees and EPFO Compliance at Maclan Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Maclan Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Maclan Pharmaceuticals Private Limited
Maclan Pharmaceuticals Private Limited has 3 board changes on record since 2010: 2 appointments and 1 cessation. The latest: Govind Prasad Chaturvedi ceased to be Director on 24 Apr 2012.
Credit Ratings, Litigation & Regulatory Alerts for Maclan Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Maclan Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Maclan Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Maclan Pharmaceuticals Private Limited
Maclan Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAGCM7807G1ZB | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Maclan Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maclan Pharmaceuticals Private Limited
Maclan Pharmaceuticals is an active private limited company based in Jaipur, Rajasthan, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 September 2010 (16+ years old) and is registered under CIN U24232RJ2010PTC032899.
Maclan Pharmaceuticals reported revenue of ₹3.34 Cr for FY 2025 (up 9% YoY).
Maclan Pharmaceuticals has 2 current directors:
- Anshul Chaturvedi - Director
- Pratibha Ojha - Director
Maclan Pharmaceuticals reported a net profit of ₹4.97 Lakh (net margin 1.5%) and EBITDA of ₹9.57 Lakh (EBITDA margin 2.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Maclan Pharmaceuticals is 11% over three years and 8% over five years. In the latest year (FY 2025) revenue rose 9%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Maclan Pharmaceuticals is 08AAGCM7807G1ZB, registered in Rajasthan.
The CIN (Corporate Identification Number) of Maclan Pharmaceuticals is U24232RJ2010PTC032899. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Maclan Pharmaceuticals has 2 court cases on record: 2 filed against it. 1 is pending.
Maclan Pharmaceuticals was incorporated on 20 September 2010, making it 16+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Maclan Pharmaceuticals by revenue are Can Pharmaceuticals Private Limited, Ghrelin Pharmaceuticals Private Limited, Bionics Remedies (Gujarat) Limited, Sai - Tech Pharmaceuticals Private Limited, Lipur Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals).
Govind Prasad Chaturvedi ceased to be Director on 24 Apr 2012. Pratibha Ojha was appointed as Director on 24 Apr 2012. Anshul Chaturvedi was appointed as Director on 20 Sep 2010.